Company Filing History:
Years Active: 1995
Title: The Innovative Mind of Peter Deil
Introduction
Peter Deil, an inventive spirit from Frankfurt am Main, Germany, holds a significant patent in the realm of biochemistry. His pioneering work has contributed to the understanding and production of insulin derivatives, showcasing the intersection of science and innovation in the pharmaceutical industry.
Latest Patents
Peter Deil is credited with a noteworthy patent titled "Amorphous monospheric forms of insulin derivatives." This patent describes a groundbreaking process for producing an amorphous monospheric form of insulin derivatives. The innovative method involves dissolving the insulin derivative in a mixture of n-propanol and buffer solution at a pH ranging from 4.5 to 6.5, ensuring an n-propanol content of over 13% relative to water, followed by a dilution with water. This advancement could potentially improve the efficacy and delivery of insulin treatments.
Career Highlights
Peter Deil is associated with Hoechst Aktiengesellschaft, a company renowned for its contributions to the pharmaceutical and chemical industries. His role at Hoechst has showcased not just his inventiveness but also his commitment to scientific advancement. With his technical expertise, he has helped propel research in insulin derivatives to new heights.
Collaborations
Throughout his career, Peter has worked alongside prominent colleagues like Rainer Obermeier and Walter Sabel. Their collaborative efforts within the company have fostered an environment ripe for innovation and have contributed to the development of significant scientific advancements in the field of biotechnology.
Conclusion
Peter Deil’s contributions through his patent on insulin derivatives exemplify the importance of innovation in healthcare. His work not only enhances our understanding of insulin formulations but also illustrates the pivotal role of inventors in transforming scientific ideas into practical applications. As a member of Hoechst Aktiengesellschaft and in collaboration with esteemed colleagues, Peter continues to be a vital figure in the landscape of biochemistry.